174 related articles for article (PubMed ID: 25501063)
1. The polymorphism of CYP2E1 Rsa I/Pst I gene and susceptibility to respiratory system cancer: a systematic review and meta-analysis of 34 studies.
Xu L; Yang M; Zhao T; Jin H; Xu Z; Li M; Chen H
Medicine (Baltimore); 2014 Dec; 93(27):e178. PubMed ID: 25501063
[TBL] [Abstract][Full Text] [Related]
2. Roles of cytochrome P4502E1 gene polymorphisms and the risks of alcoholic liver disease: a meta-analysis.
Zeng T; Guo FF; Zhang CL; Song FY; Zhao XL; Xie KQ
PLoS One; 2013; 8(1):e54188. PubMed ID: 23335995
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 2E1 RsaI/PstI polymorphism is associated with urologic cancer risk: evidence from a meta-analysis.
Lin YC; Wu X; Zhou XQ; Ren R; Su ZX; Liu CX
Int J Clin Exp Med; 2015; 8(6):8927-37. PubMed ID: 26309545
[TBL] [Abstract][Full Text] [Related]
4. [Meta-analysis on association between genetic polymorphisms of cytochrome P450 2E1 and susceptibility to Chinese gastric cancer].
Mi Y; Liang X; Wu J
Wei Sheng Yan Jiu; 2018 May; 47(3):476-481. PubMed ID: 30082020
[TBL] [Abstract][Full Text] [Related]
5. CYP2E1 RsaI/PstI polymorphisms contributed to oral cancer susceptibility: a meta-analysis.
Guo Y; Zhou S; Liu F; Zhang B
Int J Clin Exp Pathol; 2015; 8(11):14685-92. PubMed ID: 26823792
[TBL] [Abstract][Full Text] [Related]
6. Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.
Peng H; Xie SK; Huang MJ; Ren DL
Tumour Biol; 2013 Aug; 34(4):2389-95. PubMed ID: 23595220
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of CYP2E1 polymorphisms in liver carcinogenesis.
Fu P; Yang F; Li B; Zhang B; Guan L; Sheng J; Ye Y; Wang Z; Li P; Xu L; Zou L; Li W
Dig Liver Dis; 2017 Jan; 49(1):77-83. PubMed ID: 27637154
[TBL] [Abstract][Full Text] [Related]
8. Does CYP2E1 RsaI/PstI polymorphism confer head and neck carcinoma susceptibility?: A meta-analysis based on 43 studies.
Zhuo X; Song J; Liao J; Zhou W; Ye H; Li Q; Xiang Z; Zhang X
Medicine (Baltimore); 2016 Oct; 95(43):e5156. PubMed ID: 27787372
[TBL] [Abstract][Full Text] [Related]
9. Association between CYP2E1 genetic polymorphisms and urinary cancer risk: a meta-analysis.
Fang Z; Wu Y; Zhang N
Oncotarget; 2017 Oct; 8(49):86853-86864. PubMed ID: 29156840
[TBL] [Abstract][Full Text] [Related]
10. CYP2E1 RsaI/PstI polymorphism and gastric cancer susceptibility: meta-analyses based on 24 case-control studies.
Zhuo W; Zhang L; Wang Y; Ling J; Zhu B; Chen Z
PLoS One; 2012; 7(11):e48265. PubMed ID: 23139769
[TBL] [Abstract][Full Text] [Related]
11. CYP2E1 Rsa Ι/Pst Ι polymorphism and lung cancer susceptibility: a meta-analysis involving 10,947 subjects.
Shen ZT; Wu XH; Li B; Shen JS; Wang Z; Li J; Zhu XX
J Cell Mol Med; 2015 Sep; 19(9):2136-42. PubMed ID: 25945422
[TBL] [Abstract][Full Text] [Related]
12. CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis.
Niu Y; Hu Y; Wu M; Jiang F; Shen M; Tang C; Chen N
Mol Biol Rep; 2012 Jan; 39(1):607-12. PubMed ID: 21553050
[TBL] [Abstract][Full Text] [Related]
13. CYP2E1 PstI/RsaI polymorphism and interaction with alcohol consumption in hepatocellular carcinoma susceptibility: evidence from 1,661 cases and 2,317 controls.
Liu C; Wang H; Pan C; Shen J; Liang Y
Tumour Biol; 2012 Aug; 33(4):979-84. PubMed ID: 22249978
[TBL] [Abstract][Full Text] [Related]
14. CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians.
Zhan P; Wang J; Zhang Y; Qiu LX; Zhao SF; Qian Q; Wei SZ; Yu LK; Song Y
Lung Cancer; 2010 Jul; 69(1):19-25. PubMed ID: 19796841
[TBL] [Abstract][Full Text] [Related]
15. CYP2E1 PstI/RsaI polymorphism and colorectal cancer risk: a meta-analysis.
Zhou GW; Hu J; Li Q
World J Gastroenterol; 2010 Jun; 16(23):2949-53. PubMed ID: 20556843
[TBL] [Abstract][Full Text] [Related]
16. Functional PstI/RsaI polymorphism in CYP2E1 is associated with the development, progression and poor outcome of gastric cancer.
Feng J; Pan X; Yu J; Chen Z; Xu H; El-Rifai W; Zhang G; Xu Z
PLoS One; 2012; 7(9):e44478. PubMed ID: 22957075
[TBL] [Abstract][Full Text] [Related]
17. Functional RsaI/PstI polymorphism in cytochrome P450 2E1 contributes to bladder cancer susceptibility: evidence from a meta-analysis.
Deng XD; Gao Q; Zhang B; Zhang LX; Zhang W; Mu Er ZE; Xie Y; Ma Y; Liu Y
Asian Pac J Cancer Prev; 2014; 15(12):4977-82. PubMed ID: 24998574
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 2E1 gene polymorphism and alcohol drinking on the risk of hepatocellular carcinoma: a meta-analysis.
Liu W; Tian F; Dai L; Chai Y
Mol Biol Rep; 2014 Nov; 41(11):7645-50. PubMed ID: 25185993
[TBL] [Abstract][Full Text] [Related]
19. CYP2E1 Rsa I/Pst I polymorphism and esophageal cancer risk: a meta-analysis based on 1,088 cases and 2,238 controls.
Niu Y; Yuan H; Leng W; Pang Y; Gu N; Chen N
Med Oncol; 2011 Mar; 28(1):182-7. PubMed ID: 20195803
[TBL] [Abstract][Full Text] [Related]
20. [Cytochrome P450 1A1 and cytochrome P450 2E1 gene polymorphisms in Guangzhou Hans].
Wang J; Liu Z; Lu X; Chen B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Aug; 17(4):259-61. PubMed ID: 10932010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
